CLVS logo

Clovis Oncology (CLVS) Retained Earnings

CLVS Annual Retained Earnings

-$2.88 B
-$264.52 M-10.12%

31 December 2021

CLVS Retained Earnings Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CLVS Quarterly Retained Earnings

-$3.06 B
-$56.01 M-1.86%

30 September 2022

CLVS Quarterly Retained Earnings Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CLVS Retained Earnings Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-10.1%-9.0%
3 y3 years-56.1%-43.0%
5 y5 years-94.8%-115.0%

CLVS Retained Earnings High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time+5138.1%+5479.5%

Clovis Oncology Retained Earnings History

DateAnnualQuarterly
Sept 2022
-
-$3.06 B(+1.9%)
June 2022
-
-$3.01 B(+2.4%)
Mar 2022
-
-$2.94 B(+2.1%)
Dec 2021
-$2.88 B(+10.1%)
-$2.88 B(+2.3%)
Sept 2021
-
-$2.81 B(+2.5%)
June 2021
-
-$2.75 B(+2.5%)
Mar 2021
-
-$2.68 B(+2.5%)
Dec 2020
-$2.61 B(+16.5%)
-$2.61 B(+3.9%)
Sept 2020
-
-$2.51 B(+3.2%)
June 2020
-
-$2.44 B(+3.9%)
Mar 2020
-
-$2.34 B(+4.4%)
Dec 2019
-$2.24 B(+21.7%)
-$2.24 B(+4.6%)
Sept 2019
-
-$2.14 B(+4.6%)
June 2019
-
-$2.05 B(+6.2%)
Mar 2019
-
-$1.93 B(+4.7%)
Dec 2018
-$1.84 B(+24.7%)
-$1.84 B(+5.7%)
Sept 2018
-
-$1.74 B(+5.4%)
June 2018
-
-$1.65 B(+6.5%)
Mar 2018
-
-$1.55 B(+5.1%)
Dec 2017
-$1.48 B(+30.6%)
-$1.48 B(+3.6%)
Sept 2017
-
-$1.43 B(+4.4%)
June 2017
-
-$1.36 B(+14.7%)
Mar 2017
-
-$1.19 B(+5.2%)
Dec 2016
-$1.13 B
-$1.13 B(+6.7%)
DateAnnualQuarterly
Sept 2016
-
-$1.06 B(+6.6%)
June 2016
-
-$994.62 M(+14.9%)
Mar 2016
-
-$865.31 M(+10.7%)
Dec 2015
-$781.91 M(+82.2%)
-$781.91 M(+18.0%)
Sept 2015
-
-$662.37 M(+17.5%)
June 2015
-
-$563.72 M(+14.5%)
Mar 2015
-
-$492.19 M(+14.7%)
Dec 2014
-$429.05 M(+59.5%)
-$429.05 M(+14.7%)
Sept 2014
-
-$374.14 M(+11.9%)
June 2014
-
-$334.50 M(+11.6%)
Mar 2014
-
-$299.73 M(+11.4%)
Dec 2013
-$269.01 M(+45.8%)
-$269.01 M(+12.2%)
Sept 2013
-
-$239.81 M(+9.3%)
June 2013
-
-$219.49 M(+9.7%)
Mar 2013
-
-$200.15 M(+8.5%)
Dec 2012
-$184.48 M(+67.0%)
-$184.48 M(+12.9%)
Sept 2012
-
-$163.42 M(+12.6%)
June 2012
-
-$145.16 M(+12.1%)
Mar 2012
-
-$129.50 M(+17.2%)
Dec 2011
-$110.50 M(+101.2%)
-$110.50 M(+15.3%)
Sept 2011
-
-$95.84 M(+17.2%)
June 2011
-
-$81.76 M(+29.2%)
Mar 2011
-
-$63.26 M(+15.2%)
Dec 2010
-$54.93 M
-$54.93 M

FAQ

  • What is Clovis Oncology annual retained earnings?
  • What is the all time high annual retained earnings for Clovis Oncology?
  • What is Clovis Oncology annual retained earnings year-on-year change?
  • What is Clovis Oncology quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Clovis Oncology?
  • What is Clovis Oncology quarterly retained earnings year-on-year change?

What is Clovis Oncology annual retained earnings?

The current annual retained earnings of CLVS is -$2.88 B

What is the all time high annual retained earnings for Clovis Oncology?

Clovis Oncology all-time high annual retained earnings is -$54.93 M

What is Clovis Oncology annual retained earnings year-on-year change?

Over the past year, CLVS annual retained earnings has changed by -$264.52 M (-10.12%)

What is Clovis Oncology quarterly retained earnings?

The current quarterly retained earnings of CLVS is -$3.06 B

What is the all time high quarterly retained earnings for Clovis Oncology?

Clovis Oncology all-time high quarterly retained earnings is -$54.93 M

What is Clovis Oncology quarterly retained earnings year-on-year change?

Over the past year, CLVS quarterly retained earnings has changed by -$251.90 M (-8.96%)